NMO-IgG detected in CSF in seronegative neuromyelitis optica.
作者信息
Klawiter E C, Alvarez E, Xu J, Paciorkowski A R, Zhu L, Parks B J, Cross A H, Naismith R T
机构信息
Neurology, Box 8111, 660 S. Euclid Ave., Washington University, St. Louis, MO 63110, USA.
出版信息
Neurology. 2009 Mar 24;72(12):1101-3. doi: 10.1212/01.wnl.0000345066.57745.50.
Abstract
摘要
相似文献
1
NMO-IgG detected in CSF in seronegative neuromyelitis optica.
Neurology. 2009 Mar 24;72(12):1101-3. doi: 10.1212/01.wnl.0000345066.57745.50.
2
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
Neurology. 2009 Jun 2;72(22):1960-1. doi: 10.1212/WNL.0b013e3181a82621.
3
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Brain. 2007 May;130(Pt 5):1235-43. doi: 10.1093/brain/awm062. Epub 2007 Apr 19.
4
Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.
J Neurol. 2009 Feb;256(2):287-8. doi: 10.1007/s00415-009-0139-4. Epub 2009 Mar 5.
5
Neuromyelitis optica.
Curr Opin Neurol. 2007 Jun;20(3):255-60. doi: 10.1097/WCO.0b013e32814f1c6b.
6
Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.
J Neurol. 2007 Sep;254(9):1233-7. doi: 10.1007/s00415-007-0509-8. Epub 2007 Apr 2.
7
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Int J Mol Sci. 2016 Mar 2;17(3):273. doi: 10.3390/ijms17030273.
8
CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.
Neurology. 2011 Mar 22;76(12):1108-10. doi: 10.1212/WNL.0b013e318211c379.
9
Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.
Chin Med J (Engl). 2012 Jan;125(2):270-4.
10
[Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
Ugeskr Laeger. 2013 May 6;175(19):1331-5.
引用本文的文献
1
Neuromyelitis Optica Spectrum Disorder Mimicking Pontine Stroke: A Case Report and Systematic Literature Review.
Cureus. 2023 Jun 28;15(6):e41099. doi: 10.7759/cureus.41099. eCollection 2023 Jun.
2
Reflections from a NMOSD case with serum AQP4-Ab negativity but CSF positivity: narrative review of how to interpret AQP4-Ab test results.
Ann Transl Med. 2023 Apr 15;11(7):286. doi: 10.21037/atm-20-4110. Epub 2021 Jul 14.
3
Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy.
Front Neurol. 2022 May 20;13:912050. doi: 10.3389/fneur.2022.912050. eCollection 2022.
4
A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines.
Front Neurol. 2022 Feb 24;13:796882. doi: 10.3389/fneur.2022.796882. eCollection 2022.
5
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
J Neuroinflammation. 2021 Sep 16;18(1):208. doi: 10.1186/s12974-021-02249-1.
6
The Emerging Role of Microglia in Neuromyelitis Optica.
Front Immunol. 2021 Feb 19;12:616301. doi: 10.3389/fimmu.2021.616301. eCollection 2021.
7
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
Eye (Lond). 2021 Mar;35(3):753-768. doi: 10.1038/s41433-020-01334-8. Epub 2020 Dec 15.
8
Differential Diagnosis of Pediatric Multiple Sclerosis.
Children (Basel). 2019 Jun 3;6(6):75. doi: 10.3390/children6060075.
9
Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity.
J Immunol. 2019 Apr 15;202(8):2210-2219. doi: 10.4049/jimmunol.1801295. Epub 2019 Mar 1.
10
Update on neuromyelitis optica: natural history and management.
Eye Brain. 2012 Mar 26;4:27-41. doi: 10.2147/EB.S8392. eCollection 2012.
本文引用的文献
1
NMO-IgG predicts the outcome of recurrent optic neuritis.
Neurology. 2008 Jun 3;70(23):2197-200. doi: 10.1212/01.wnl.0000303817.82134.da. Epub 2008 Apr 23.
2
The spectrum of neuromyelitis optica.
Lancet Neurol. 2007 Sep;6(9):805-15. doi: 10.1016/S1474-4422(07)70216-8.
3
Revised diagnostic criteria for neuromyelitis optica.
Neurology. 2006 May 23;66(10):1485-9. doi: 10.1212/01.wnl.0000216139.44259.74.
4
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.
Ann Neurol. 2006 Mar;59(3):566-9. doi: 10.1002/ana.20770.
5
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
J Exp Med. 2005 Aug 15;202(4):473-7. doi: 10.1084/jem.20050304. Epub 2005 Aug 8.
6
An open label study of the effects of rituximab in neuromyelitis optica.
Neurology. 2005 Apr 12;64(7):1270-2. doi: 10.1212/01.WNL.0000159399.81861.D5.
7
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Lancet. 2004;364(9451):2106-12. doi: 10.1016/S0140-6736(04)17551-X.
Zotero 插件